title: [Miliary tuberculosis after intravesical Bacillus Calmette-Guerin administration].
authors.forename: J
authors.initials: J
authors.lastname: Reparaz
authors.forename: J
authors.initials: J
authors.lastname: Uriz
authors.forename: J
authors.initials: J
authors.lastname: Castiello
authors.forename: J
authors.initials: J
authors.lastname: Sola
mesh_terms: D000283:Administration, Intravesical; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D002277:Carcinoma / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D016867:Immunocompromised Host; D016233:Immunotherapy, Active; D008297:Male; D009163:Mycobacterium bovis / Q000302:isolation & purification*; D014391:Tuberculosis, Miliary / Q000209:etiology* / Q000382:microbiology; D001749:Urinary Bladder Neoplasms / Q000628:therapy
chemical_list: D001500:BCG Vaccine
vernacular_title: Tuberculosis miliar tras administración intravesical de bacilo de Calmette-Guerin.